Current Report Filing (8-k)
April 10 2018 - 6:31AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 5, 2018
M
IRATI
T
HERAPEUTICS
, I
NC
.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-35921
|
|
46-2693615
|
(State of
incorporation)
|
|
(Commission
File No.)
|
|
(IRS Employer
Identification No.)
|
9393 Towne Centre Drive, Suite 200
San Diego, California 92121
(Address of principal executive offices and zip code)
Registrants telephone number, including area code:
(858) 332-3410
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (see General Instruction A.2. below):
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to
Rule 14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to
Rule 14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to
Rule 13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 or Rule
12b-2
of the Securities Exchange Act of 1934.
Emerging
growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒
Item 1.01
|
Entry into a Material Definitive Agreement
|
On April 5, 2018, the Company entered into a Second
Amendment to Lease Agreement (the Amendment) with
ARE-SD
Region No. 20 (the Landlord) to amend the Lease Agreement, dated June 24, 2014, and the First Amendment to Lease dated
March 23, 2017 (the Amended Lease) between the Company and Landlord. The Amendment extends the term of the Amended Lease for one year through January 31, 2020. All other material terms and covenants from the Amended Lease
remain unchanged.
A copy of the Amendment is filed as Exhibit 10.1 to this report and the description of the terms of the Amendment is qualified in its
entirety by reference to such exhibit.
Item 9.01
|
Financial Statements and Exhibits.
|
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
M
IRATI
T
HERAPEUTICS
,
I
NC
.
|
|
|
|
|
Date: April 10, 2018
|
|
|
|
By:
|
|
/s/ Jamie A. Donadio
|
|
|
|
|
|
|
Jamie A. Donadio
|
|
|
|
|
|
|
Senior Vice President and Chief Financial Officer
|
Mirati Therapeutics (NASDAQ:MRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Mirati Therapeutics (NASDAQ:MRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024